InMed Pharmaceuticals reported net income of -$2.97M for the quarter ended Mar 2026. This income statement covers 27 quarters of results from Sep 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||
| Revenue | 0.27M | 0.60M | 0.51M | 0.32M | 0.47M | 1.03M | 2.31M | 0.90M | 1.24M | 1.17M | 1.28M | 1.26M | 1.11M | 1.26M | 1.30M | 1.12M | 0.82M | ||||||||||
| Cost of RevenueCost of Rev | 0.15M | 0.13M | 0.27M | 0.24M | 0.34M | 0.84M | 1.32M | 0.88M | 0.92M | 0.88M | 0.82M | 0.77M | 0.65M | 1.09M | 0.73M | 0.72M | 0.64M | ||||||||||
| Gross Profit | 0.11M | 0.18M | 0.25M | -0.49M | 0.13M | 0.19M | 1.57M | 0.02M | 0.32M | 0.29M | 0.47M | 0.49M | 0.46M | 0.18M | 0.58M | 0.40M | 0.18M | ||||||||||
| Operating items | |||||||||||||||||||||||||||
| Depreciation & Amortization - TotalDep. & Amort. (Tot) | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | ||||||||||||||||
| Research & DevelopmentR&D | 1.72M | 1.49M | 2.54M | 1.75M | 1.50M | 1.38M | 0.85M | 0.88M | 0.62M | 1.29M | 0.61M | 0.66M | 0.66M | 0.70M | 0.90M | 0.43M | 0.61M | 0.58M | 0.63M | 1.02M | |||||||
| Selling, General & AdministrativeSG&A | 3.26M | 1.37M | 1.84M | 1.92M | 1.74M | 1.56M | 1.46M | 1.41M | 1.41M | 1.30M | 1.36M | 1.37M | 1.76M | 1.49M | 1.72M | 1.58M | 2.40M | 1.53M | 1.62M | 1.74M | |||||||
| Restructuring CostsRestructuring | 0.04M | 0.03M | 0.23M | 0.01M | 0.01M | 0.10M | |||||||||||||||||||||
| Other Operating ExpensesOther Opex | -1.67M | 0.03M | 0.05M | 0.05M | 3.53M | 0.15M | -0.02M | 0.01M | -0.22M | 0.09M | -0.03M | 0.08M | -0.03M | 0.02M | 0.09M | 0.06M | 0.02M | 0.11M | 0.04M | 0.07M | |||||||
| Operating ExpensesOpex | 3.31M | 2.89M | 4.42M | 3.72M | 6.77M | 3.08M | 2.35M | 2.34M | 2.06M | 2.69M | 1.97M | 2.13M | 2.50M | 2.23M | 2.71M | 2.08M | 3.04M | 2.22M | 2.29M | 2.84M | |||||||
| Operating IncomeOp. Inc | -4.31M | -3.54M | -6.52M | -3.58M | -2.21M | -2.15M | -0.49M | -2.67M | -1.64M | -1.84M | -2.03M | -1.73M | -2.25M | -1.91M | -2.47M | -1.82M | -2.10M | ||||||||||
| EBIT | -2.97M | -4.31M | -3.54M | -6.52M | -3.58M | -2.21M | -2.15M | -0.49M | -2.67M | -1.64M | -1.84M | -2.03M | -1.73M | -2.25M | -1.91M | -2.47M | -1.82M | -2.10M | -2.79M | ||||||||
| Non-operating items | |||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.01M | 0.03M | 0.03M | 0.03M | 0.07M | 0.12M | 0.16M | 0.15M | 0.14M | 0.17M | 0.12M | 0.10M | 0.06M | 0.03M | 0.02M | 0.05M | 0.09M | 0.07M | 0.05M | |||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.08M | 0.00M | 0.03M | -0.07M | -0.10M | 0.02M | -0.00M | 0.03M | -0.05M | 0.06M | -0.05M | -0.03M | 0.02M | -0.05M | -0.02M | 0.02M | -0.06M | 0.02M | -0.02M | ||||||||
| Non Operating IncomeNon Op. Inc. | 0.16M | 0.15M | 0.12M | 0.10M | |||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||
| EBT | -2.97M | -4.28M | -3.48M | -7.87M | -3.50M | -2.10M | -2.00M | -0.34M | -2.54M | -1.48M | -1.72M | -1.93M | -1.68M | -2.58M | -2.07M | -1.31M | -1.73M | -2.03M | -2.79M | ||||||||
| Tax ProvisionsTaxes | 0.01M | ||||||||||||||||||||||||||
| Profit After TaxPAT | -2.05M | -2.97M | -4.28M | -3.48M | -7.87M | -3.51M | -2.10M | -2.00M | -0.34M | -2.54M | -1.48M | -1.72M | -1.96M | -1.68M | -2.58M | -2.12M | -1.34M | -1.73M | -2.03M | -2.97M | |||||||
| Income from Non-Controlling InterestsInc. Minority | 0.35M | 0.02M | |||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -2.97M | -4.28M | -3.48M | -7.87M | -3.51M | -2.10M | -2.00M | -0.34M | -2.54M | -1.48M | -1.72M | -1.93M | -1.68M | -2.58M | -2.07M | -1.31M | -1.73M | -2.03M | -2.79M | ||||||||
| Income from Discontinued OperationsIncome (Discontinued) | -0.05M | -0.17M | |||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -2.97M | -4.28M | -3.48M | -7.87M | -3.51M | -2.10M | -2.00M | -0.34M | -2.54M | -1.48M | -1.72M | -1.93M | -1.68M | -2.58M | -2.12M | -1.31M | -1.73M | -2.03M | -2.97M | ||||||||
| Income towards Parent CompanyParent Net Inc | -2.97M | -4.28M | -3.48M | -7.87M | -3.51M | -2.10M | -2.00M | -0.34M | -2.54M | -1.48M | -1.72M | -1.93M | -1.68M | -2.58M | -2.12M | -1.31M | -1.73M | -2.03M | -2.97M | ||||||||
| Net Income towards Common StockholdersNet Income | -2.97M | -4.28M | -3.48M | -7.87M | -3.51M | -2.10M | -2.00M | -0.34M | -2.54M | -1.48M | -1.72M | -1.93M | -1.68M | -2.58M | -2.12M | -1.31M | -1.73M | -2.03M | -2.97M | ||||||||
| Additional items | |||||||||||||||||||||||||||
| EPS (Basic) | -123.33 | -154.64 | -122.80 | -280.66 | -81.10 | -18.24 | -12.00 | -2.75 | -15.24 | -3.71 | -3.58 | -5.07 | -2.71 | -3.64 | -1.94 | -1.34 | -0.44 | -0.51 | -0.73 | ||||||||
| EPS (Diluted) | -4.93 | -6.19 | -4.91 | -280.66 | -81.10 | -18.24 | -12.00 | -2.75 | -15.24 | -3.71 | -3.58 | -5.07 | -2.71 | -3.64 | -1.94 | -1.34 | -0.44 | -0.51 | -0.73 | ||||||||
| Shares Outstanding | 0.34M | 0.02M | 0.03M | 0.03M | 0.03M | 0.04M | 0.12M | 0.17M | 0.12M | 0.17M | 0.40M | 0.48M | 0.38M | 0.62M | 0.71M | 1.10M | 0.98M | 3.95M | 3.95M | 4.05M | |||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.34M | 0.60M | 0.69M | 0.71M | 0.03M | 0.04M | 0.12M | 0.17M | 0.12M | 0.17M | 0.40M | 0.48M | 0.38M | 0.62M | 0.71M | 1.10M | 0.98M | 3.95M | 3.95M | 4.05M | |||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.40M | 0.02M | 0.03M | 0.03M | 0.03M | 0.05M | 0.12M | 0.17M | 0.12M | 0.17M | 0.40M | 0.48M | 0.45M | 0.67M | 0.72M | 1.21M | 0.98M | 3.95M | 3.95M | 3.31M | |||||||
| EBITDA | -2.97M | -4.31M | -3.54M | -6.52M | -3.58M | -2.21M | -2.14M | -0.47M | -2.66M | -1.63M | -1.83M | -2.03M | -1.72M | -2.24M | -1.90M | -2.46M | -1.82M | -2.10M | -2.79M | ||||||||
| Tax Rate | -0.19% |